Subspecialties: Page 1411

FLT-PET shows promise in differentiating unclear lung lesions

By Jonathan S. Batchelor

FDG has long shown its efficacy in demonstrating the metabolic differences between benign and malignant lung tumors. However, the radiotracer is not tumor-specific. German researchers are investigating fluorothymidine (FLT) as an alternative radiotracer for therapy response in non-small cell lung cancer.

September 30, 2003

Edwards debuts non-coronary stents

By AuntMinnie.com staff writers

Medical device developer Edwards Lifesciences has introduced two pre-mounted, balloon-expandable stents in Europe and the U.S.

September 29, 2003

Molecular Imaging Radiology Insider

By Jonathan S. Batchelor

Physicians who diagnose gall bladder dyskinesia will remember 2001 as the year Bristol-Myers Squibb turned off the tap on Kinevac, a synthetic cholecystokinin drug used in cholescintigraphy. A year later, in December 2002, Bracco Diagnostics resumed manufacturing and marketing the product.

September 28, 2003

IPL releases cobalt-57 flood source

By AuntMinnie.com staff writers

Nuclear medicine developer Isotope Products Laboratories is scheduled to begin shipments of a cobalt-57 flood source, Perflexion, the first week of October.

September 28, 2003

MR categorizes acute hamstring injuries for pre-op assessment

By Shalmali Pal

For the sports medicine imaging specialist, distinguishing tendon avulsion from hamstring muscle complex strain can determine whether the patient will wind up in the surgical suite. Australian researchers relied on MR and sonography to make that distinction, reporting their results in the online issue of Skeletal Radiology.

September 28, 2003

CT follow-up improves confidence in borderline kidney lesions

By Tracie L. Thompson

In this month’s American Journal of Roentgenology, Dr. Morton Bosniak offers further suggestions from his experience with the lesions he places in Category IIF, where F stands for follow-up.

September 28, 2003